Edwards Lifesciences Corp (EW.N)
12 Feb 2016
* Q4 Transcatheter Heart Valve therapy (THV) sales $334.3 million, up 25 percent
Feb 2 Edwards Lifesciences Corp raised its full-year earnings forecast on Tuesday, anticipating stronger sales of its artificial heart valves implanted in a minimally invasive procedure that spares patients from open-chest surgery.
Oct 26 Edwards Lifesciences Corp reported better-than-expected third-quarter earnings and raised its full-year forecast on Monday, citing strong demand for its replacement heart valves that are implanted in minimally invasive procedures.
Oct 26 Edwards Lifesciences Corp on Monday reported stronger-than-expected third-quarter earnings on demand for its replacement heart valves that are implanted in minimally invasive procedures.